A Conditional Deletion of the NR1 Subunit of the NMDA Receptor in Adult Spinal Cord Dorsal Horn Reduces NMDA Currents and Injury-Induced Pain by South, Samantha M. et al.
A Conditional Deletion of the NR1 Subunit of the NMDA
Receptor in Adult Spinal Cord Dorsal Horn Reduces NMDA
Currents and Injury-Induced Pain
Samantha M. South,1 Tatsuro Kohno,2 Brian K. Kaspar,3 Deborah Hegarty,1 Bryce Vissel,3 Carrie T. Drake,1
Megumi Ohata,1 Shirzad Jenab,1 Andreas W. Sailer,3 Shelle Malkmus,4 Takashi Masuyama,4 Philip Horner,3
Johanna Bogulavsky,1 Fred H. Gage,3 Tony L.Yaksh,4 Clifford J. Woolf,2 Stephen F. Heinemann,3 and
Charles E. Inturrisi1
1Departments of Pharmacology and Neuroscience, Weill Medical College of Cornell University, New York, New York 10021, 2Neural Plasticity Research
Group, Department of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129,
3Laboratory of Genetics and of Molecular Neurobiology, The Salk Institute for Biological Studies, La Jolla, California 92037, and 4Department of
Anesthesiology, University of California, San Diego, La Jolla, California 92093
To determine the importance of the NMDA receptor (NMDAR) in pain hypersensitivity after injury, the NMDAR1 (NR1) subunit was
selectively deleted in the lumbar spinal cord of adult mice by the localized injection of an adenoassociated virus expressing Cre recom-
binase into floxed NR1 mice. NR1 subunit mRNA and dendritic protein are reduced by 80% in the area of the virus injection, and NMDA
currents, but not AMPA currents, are reduced 86 – 88% in lamina II neurons. The spatial NR1 knock-out does not alter heat or cold
paw-withdrawal latencies, mechanical threshold, or motor function. However, injury-induced pain produced by intraplantar formalin is
reduced by 70%. Our results demonstrate conclusively that the postsynaptic NR1 receptor subunit in the lumbar dorsal horn of the spinal
cord is required for central sensitization, the central facilitation of pain transmission produced by peripheral injury.
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Introduction
Glutamate receptors are the major transducer of excitatory neu-
rotransmission, the means by which information on injury in the
periphery is conveyed, via primary sensory neurons, to the CNS,
where the sensation of pain is realized (Dubner and Ruda, 1992;
Woolf and Costigan, 1999). The spinal cord dorsal horn (SCDH)
is the initial site of integration for ascending and descending in-
formation on pain (Woolf and Salter, 2000). Intense or sustained
noxious stimuli that are associated with tissue injury result in a
temporal summation of postsynaptic depolarizations, which
have been argued to remove the voltage-dependent magnesium
block of NMDA ionotropic glutamate receptors, allowing cal-
cium influx into the postsynaptic cell (Woolf and Salter, 2000).
This influx in turn will activate calcium-sensitive intracellular
signal cascades (Woolf and Costigan, 1999) that lead to the phos-
phorylation of the NMDA and other receptor–ion channels, ini-
tiating prolonged increases in the excitability of spinal cord neu-
rons, a process described as central sensitization (Woolf and
Costigan, 1999; Woolf and Salter, 2000). Central sensitization
results in increased synaptic efficacy, and the recruitment of nor-
mally subliminal inputs leads to the spread of pain sensitivity
beyond the site of injury (secondary hyperalgesia) and the gener-
ation of pain in response to low-threshold inputs (allodynia)
(Woolf and Salter, 2000). The mechanisms underlying this pain
hypersensitivity have features that resemble the synaptic plastic-
ity in the hippocampus that underlies learning and memory, for
which NMDA receptors (NMDARs) also have been shown to be
crucial (Hollmann and Heinemann, 1994; Tsien et al., 1996;
Dingledine et al., 1999). Pharmacological antagonism of NMDA
receptors (Woolf and Thompson, 1991; Yamamoto and Yaksh,
1992) does not usually interfere with the nociceptive response to
normal non-tissue-damaging noxious stimuli (basal pain sensi-
tivity) but reduces the initiation and maintenance of central sen-
sitization (Woolf and Salter, 2000). However, the evidence has
relied on drugs (competitive and noncompetitive NMDA recep-
tor antagonists) for which the specificity, site, duration, and ex-
tent of action on local targets are either not fully known or cannot
be controlled. In the hippocampus, disruption of NMDA recep-
tor function by a deletion of the NMDAR1 (NR1) subunit of the
multimeric NMDA receptor, conditionally restricted to the CA1
region of adult mice, has provided evidence for the essential role
of the NMDA receptor in the acquisition of spatial memories
(Tsien et al., 1996). The Cre–loxP recombination system pro-
vides an approach for spatial and temporal control of gene dele-
tion in the CNS (Tsien et al., 1996; Kaspar et al., 2002b). An
intramolecular recombination catalyzed by Cre results in the de-
letion of an essential DNA sequence between the two loxP sites,
which have been introduced into the gene of interest at a location
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that does not interfere with transcription (Tsien et al., 1996). We
modified the approach of Tsien et al. (1996) by using a recombi-
nant adenoassociated virus (rAAV) (Kaspar et al., 2002b) to de-
liver Cre recombinase to the lumbar SCDH of an adult floxed
mouse, allowing the specific role of SCDH NMDA receptors in
injury-induced pain to be determined.
Materials and Methods
The floxed NMDA receptor 1 subunit mutant mouse
Mice, which were homozygous for the floxed NR1 subunit (fNR1) gene,
were as described previously (Tsien et al., 1996). These mice have a loxP
site placed in the intron that lies between exons 10 and 11 and a second
loxP site downstream after exon 22, the last exon. The two loxP sequences
flank a region of the NR1 gene that encodes the four membrane domains
[three transmembrane (TM) domains and the M2 recurrent loop] and
the entire C-terminal sequence of the polypeptide chain (Tsien et al.,
1996). Adult (30 – 40 gm) fNR1 mice of both sexes were used in these
studies. The animals used for the breeding of the fNR1 line were tested for
homozygosity of the loxP sites using the Southern blot procedure, and
the MAX-BAX (Charles River Laboratories, Wilmington, MA) back-
ground strain characterization procedure was used to identify breeders
that were at least 92–95% C57BL/6 background.
The Cre-expressing rAAV vector
The vector construction, viral production, and purification were as de-
scribed by Kaspar et al. (2002b). The rAAV is a single-stranded DNA
parvovirus (4.7 kb) that is engineered without viral coding sequences.
The inserted transgene included a cytomegalovirus promoter and the
coding sequences for a fusion protein of green fluorescent protein
(GFP)-Cre. Control animals received the same dosage of a rAAV-GFP
vector that lacked the coding sequence for Cre recombinase.
Intraparenchymal administration of rAAV
Initial experiments demonstrated that when the viral vector is adminis-
tered into the CSF via an intrathecal injection, very little if any uptake of
the virus into spinal cord occurred (data not shown). Therefore, the virus
was microinjected [intraparenchymal injection (IPI)] directly into the
SCDH. The mouse was anesthetized with ketamine–xylazine and placed
in a spinal frame that supported the abdomen and pelvis, and a laminec-
tomy was used to remove spinous process VL2 and part of VL3. Three
unilateral injections of 1 l (1  10 6 viral particles/l) were adminis-
tered 0.5 mm apart, at a depth of 0.3 mm (SCDH), using a glass pipette
with a 40-m-diameter tip attached to a 5 l Hamilton syringe. The
syringe was mounted on a microinjector (model 5000; David Kopf In-
struments, Tujunga, CA) attached to a stereotaxic unit (model 960;
David Kopf Instruments). Mice were evaluated as described below after
at least 14 d had elapsed after the IPI administration of the vehicle (PBS),
rAAV-GFP-Cre, or rAAV-GFP, as described in Results.
Light-microscopic immunocytochemistry
Animals were perfused transcardially with 4% paraformaldehyde. The
spinal cord, with attached dorsal root ganglia (DRGs), was dissected and
placed into 4% paraformaldehyde for 1 hr before being cryoprotected in
30% sucrose for a minimum of 72 hr. The spinal cord was measured and
cut into 3 mm sections, frozen into a mold with optimal cutting temper-
ature compound, and then cut on a cryostat into 20 or 12m sections for
immunocytochemistry and in situ hybridization, respectively. Spinal
cord sections were incubated with antibodies (Abs) to the C terminus of
NR1 (1:500; Ab 1516), NR2A (1:1000; Ab 1555P), and NR2B (1:1000; Ab
1557P) (each from Chemicon International, Temecula, CA); with anti-
bodies to the C terminus of GFP (1:3000; 8363-2) [Clontech (Palo Alto,
CA) or Molecular Probes Inc. (Eugene, OR)] (1:1000); or with antibodies
to the C terminus of neuronal-specific nuclear protein [NeuN; 1:400;
monoclonal antibody (mAb) 377; Chemicon International]. The sec-
tions were incubated in appropriate biotinylated secondary antibodies
(BA-1000 and BA-9200; Vector Laboratories, Burlingame, CA), and im-
munoreactivity was detected with the avidin– biotin–peroxidase com-
plex (ABC)–3,3-diaminobenzidinetetrahydrochloride technique (Hsu et
al., 1981). To test the specificity of the immunolabeling, control slides
were exposed to diluted normal goat serum instead of the primary
antibody.
NR1 in situ hybridization
Slide-mounted spinal cord and DRG sections (12 m) were hybridized
with a 2.2 kb [ 33P]UTP-labeled (Perkin-Elmer Life Sciences, Boston,
MA) antisense or sense probe directed to the region of the NR1 subunit
that includes the entire sequence that is flanked by the loxP sites. Hybrid-
ization was performed according to methods described previously (Sim-
mons et al., 1989). After the posthybridization washes, slides were dried
by dehydration, dipped in NTB-2 emulsion from Eastman Kodak (Roch-
ester, NY), and incubated at 4°C for 16 –18 d. Slides were then developed
and counterstained with hematoxylin and eosin. The reduction in SCDH
NR1 labeling was determined by comparing ipsilateral with contralateral
NR1 mRNA labeling in sections obtained from the injection site (a dis-
tance spanning1.0 mm), in sections rostral and caudal to the injection
site, where the GFP labeling was substantially reduced (the edge), and at
the midpoint between the injection site and the edge. Labeling of mRNA
and immunolabeling was estimated using the Metamorph software pro-
gram (Universal Imaging, Downingtown, PA).
Electron microscopy
Three untreated and three fNR1 mice treated with IPI of rAAV-GFP-Cre
(2 weeks previously) were deeply anesthetized with sodium pentobar-
bital (150 mg/kg, i.p.) and perfused through the ascending aorta with 5
ml of heparin-saline, followed by 40 ml of 3.75% acrolein (Polysciences,
Warrington, PA) and 2% paraformaldehyde in 0.1 M phosphate buffer,
pH 7.4. The spinal cord was removed and cut into 3-mm-thick blocks,
which were stored in acrolein-paraformaldehyde for 20 min. Transverse
sections (40 m thick) were cut through the lumbar spinal cord, incu-
bated in 1% sodium borohydride, freeze-thawed, and incubated in 0.5%
bovine serum albumin (BSA), as described by Milner and Drake (2001).
For immunolabeling, sections were placed in a mouse anti-NR1 mAb
(PharMingen, San Diego, CA) diluted 1/50 in 0.1% BSA for 40 – 48 hr at
4°C. This antibody has been characterized for specificity using the
present labeling protocol (Wang et al., 1999a; Milner and Drake, 2001).
NR1 was localized using the ABC method (Hsu et al., 1981), as described
previously by Milner and Drake (2001). The secondary antibody was
biotinylated horse anti-mouse IgG (Jackson ImmunoResearch, West
Grove, PA), and 3,3-diaminobenzidine was used to visualize labeling.
Sections for electron microscopy were embedded in EMbed (Electron
Microscopy Sciences, Fort Washington, PA), and ultrathin sections were
prepared as described by Drake and Milner (1999). Final preparations
were analyzed on a Philips CM10 electron microscope. Figures were
generated from digital images or scanned negatives using a Macintosh
8500/120, Adobe Photoshop 6.0 (Adobe Systems, San Jose, CA), and
Quark X-Press 3.2.
Sections from untreated mice were examined qualitatively to establish
the distribution of NR1 labeling and optimal labeling conditions. From
each of three treated mice, one section near the injection site was ana-
lyzed quantitatively for NR1-labeled profiles. Lamina I-II was examined
ipsilateral and contralateral to the injection site, and semirandom fields
in lamina II were chosen on the basis of good morphological preservation
and location within 50m of the plastic–tissue interface. Ten digital photo-
graphs of lamina II fields (totaling 2220m2) per dorsal horn were captured.
All profiles with NR1-immunoperoxidase labeling were counted and iden-
tified using nomenclature and morphological definitions consistent with
those of Peters et al. (1991). Profiles that lacked identifying characteristics
were classified as “unknown.”
Electrophysiology
Spinal cord slice preparation. Lumbosacral spinal cords were removed
under urethane anesthesia (1.5 gm/kg, i.p.) from fNR1 mice that received
an IPI of either rAAV-GFP (n  4) or rAAV-GFP-Cre (n  5) or from
age-matched untreated C57BL/6 mice (n 6). The isolated spinal cord
was placed in preoxygenated ice-cold Krebs’ solution (in mM: 117 NaCl,
3.6 KCl, 2.5 CaCl2, 1.2 MgCl2, 1.2 NaH2PO4, 25 NaHCO3, and 11 glu-
cose), and a 600-m-thick transverse slice with attached dorsal root
(right side in the area of rAAV injection) was cut using a vibrating mi-
croslicer (DTK1500; Dosaka, Kyoto, Japan) (Yoshimura and Jessell,
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1989; Kohno et al., 1999). The spinal cord slice was placed on nylon mesh
in the recording chamber, perfused with Krebs’ solution (10 ml/min),
and saturated with 95% O2 and 5% CO2 at 36 1°C.
Patch-clamp recording from lamina II neurons. Whole-cell patch-clamp
recordings were made from neurons located in lamina II [substantia
gelatinosa (SG)] of the SCDH (Yoshimura and Nishi, 1993; Moore et al.,
2002). In adult spinal cord slices, the SG is readily identifiable as a trans-
lucent region. For whole-cell recording, the resistance of patch pipettes
was 5–10 Mwhen filled with the internal solution (in mM: 110 Cs2SO4,
0.5 CaCl2, 2 MgCl2, 5 EGTA, 5 HEPES, 5 TEA, and 5 ATP-Mg salt).
Membrane currents were amplified with an Axopatch 200A amplifier
(Axon Instruments, Foster City, CA) in voltage-clamp mode. Signals
were filtered at 2 kHz and digitized at 5 kHz. Data were collected and
analyzed with pClamp8 software (Axon Instruments). In all neurons, the
frequency and amplitude of spontaneous EPSCs were recorded.
Dorsal root stimulation. Evoked EPSCs were recorded in lamina II
neurons by dorsal root stimulation voltage clamped to70 (AMPA) or
 40 mV (NMDA), respectively (Yoshimura and Nishi, 1993; Kohno et
al., 1999). Dorsal root stimulation demonstrates a purely synaptic re-
sponse that has a fast AMPA receptor-mediated and a slow NMDA
receptor-mediated response. In spinal cord slices from untreated, rAAV-
GFP, and rAAV-GFP-Cre mice, when A fibers were fully activated (100
A, 0.05 msec), AMPA receptor-mediated primary afferent-evoked
EPSCs were collected (70 mV). To test the NMDA synaptic response,
NMDA receptor-mediated synaptic EPSCs were observed in untreated
and rAAV-GFP-Cre mice in the presence of a glycine receptor antagonist
(strychnine; 1 M), a GABAA receptor antagonist (bicuculline; 20 M),
and an AMPA/kainate receptor antagonist (CNQX; 20 M).
Behavioral tests
Motor coordination. Each mouse was placed on a rotarod (Life Sciences
IITC, Hialeah, FL) set at 40 rpm (speed level 10). The length of time
(seconds) that the mouse remained on the rod was measured. A cutoff of
60 sec was observed (Crawley and Paylor, 1997).
Mechanical stimulus threshold. The threshold to a non-noxious me-
chanical stimulus was assessed using a set of von Frey hairs. The animal
was placed in a Plexiglas cage with mesh flooring suspended above the
researcher and left to equilibrate for 15 min. von Frey filaments were
applied perpendicularly against the midplantar surface of the foot. The
predetermined mean von Frey hair of 2 gm was presented to each foot,
and the subsequent presentation of the following filament was deter-
mined using the up– down method of Dixon, as described by Chaplan et
al. (1994).
Thermal (heat) paw-withdrawal threshold. Thermal paw withdrawal
was assessed using a thermal nociceptive stimulus (Hargreaves et al.,
1988). Animals were placed in a Plexiglas cage, placed on a preheated
glass plate maintained at 30°C, and left to equilibrate for 30 min. A
radiant thermal stimulus was focused on the midplantar surface of the
hindpaw and the latency (0.1 sec) for the withdrawal of the paw from the
heat source was determined automatically. Each paw was evaluated sep-
arately, and a maximum cutoff of 15 sec was used. Two thermal stimulus
intensities (low and high) were used.
Cold (cooling stimulus) threshold. Cold threshold sensitivity was as-
sessed using the acetone drop application method (Bridges et al., 2001).
Animals were placed in Plexiglas cages with mesh flooring at a level above
the researcher and left to equilibrate for 15 min. A drop of acetone was
placed against the midplantar surface of each hindpaw, and a positive
response (score of 1) was recorded if the animal withdrew (flinched) the
paw after application, whereas no response was given a value of 0. The
score was the mean number of positive responses observed in five con-
secutive trials.
Thermal tail withdrawal threshold. A hot water bath was heated to a
constant temperature of either 48, 52.5, or 55°C. Mice were held loosely
in a towel and the lower half of each mouse’s tail was dipped into the bath
(Bilsky et al., 1996). A timer was stopped immediately when the mouse
flicked its tail. A maximum tail withdrawal latency of 20, 15, and 10 sec,
respectively, was used as a cutoff to prevent damage to the tail.
Formalin-induced nociceptive hypersensitivity. Formalin (5%) was ad-
ministered in a volume of 20 l with a 25 l glass syringe (Hamilton
Company, Reno, NV) into the right hindpaw of a lightly restrained
mouse using a sterile 30 gauge, 0.5 inch needle. Immediately after the
formalin injection, the mouse was placed in a test chamber and observed
continuously for the next 60 min. The total time spent licking (seconds)
was recorded in 5 min intervals and divided into 0 –10 min (phase 1) and
10 – 60 min (phase 2) nociceptive responses, respectively (Elliott et al.,
1995).
Statistics
The behavioral and electrophysiology data were analyzed by an ANOVA
followed by the Student–Newman–Keuls test (multiple groups) or the t
test (two groups). The electron microscopic data (number of NR1-
labeled profiles per dorsal horn on the injected vs contralateral side) were
compared using a Mann–Whitney rank–sum test. The level of signifi-
cance was p  0.05.
Results
Viral transduction and recombination in the SCDH
Two weeks after IPI of rAAV-GFP-Cre into the adult mouse lum-
bar spinal cord, a highly localized pattern of expression of GFP
was observed, one that was restricted to the ipsilateral dorsal horn
and part of the ipsilateral ventral horn (Fig. 1A) and that per-
sisted for as long as 10 months after administration of the viral
vector. Region-specific Cre-mediated recombination was evident
where reduction in NR1 mRNA labeling was measured in an
adjacent section (Fig. 1B) by in situ hybridization using an anti-
sense riboprobe, the sequence of which spans the loxP sites that
will be deleted by the Cre-mediated recombination. The loxP
sequences flank a region of the NR1 gene that encodes the four
membrane domains (three TM domains and the M2 recurrent
loop) and the entire C-terminal sequence of the polypeptide
chain (Tsien et al., 1996). Three injections of rAAV-GFP-Cre at
0.5 mm intervals result in a segment-specific expression of GFP
and an 80% depletion of the NR1 mRNA that extends for 3.75
0.25 mm (SEM) (n  13) rostrocaudally to incorporate the L4,
L5, and L6 spinal segments. These are the target areas that com-
prise the sciatic sensory distribution from the paw to the dorsal
horn (Woolf and Swett, 1984). The extent of the GFP label cor-
related almost perfectly with the area of reduced NR1 mRNA
(Fig. 1A,B). Using this injection protocol, the entire ipsilateral
dorsal horn was effectively depleted of NR1 mRNA, leaving the
contralateral dorsal horn and nonlumbar spinal cord completely
intact. The ratio of ipsilateral to contralateral labeling of NeuN
(Fig. 1C) at 94.3  7.5% (SEM) is not significantly different,
indicating no loss of neurons. SCDH sections from animals that
received the control vector (rAAV-GFP) (n  5) showed no
difference in the ratio percentage of ipsilateral to contralateral
labeling of NR1 mRNA (96.3  7.8% SEM) or NeuN (109.2 
8.7% SEM).
NR1 labeling of individual neurons in lamina II was evident
on the contralateral side (Fig. 2A, arrows) and absent in lamina II
of the rAAV-GFP-Cre-injected side. Overall, much of the label-
ing was diffuse, and the morphological types of cells that con-
tained labeling could not be determined. Therefore, an ultra-
structural analysis was conducted to quantitatively determine
changes in NR1 protein. At the ultrastructural level, NR1 labeling
was abundant in laminas I and II of untreated fNR1 mice (data
not shown) and on the contralateral side of rAAV-GFP-Cre-
treated mice (Fig. 2B). Of the 876 neuronal NR1-labeled profiles
counted in the 2220 m 2 fields on the contralateral side, most
were dendrites (81%), followed by axons (9%), terminals (6%),
and somata (4%) (Aicher et al., 1997, 2002). Labeled dendrites
were of all sizes, indicating diffuse NR1 distribution along the
dendritic tree. Labeling in the larger dendrites and somata was
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consistent with NR1 expression in lamina II neurons, whereas the
smaller dendrites may have originated from superficial and/or
deeper neurons. Most NR1-labeled axons were small and unmy-
elinated. Labeled terminals were heterogeneous, ranging in size
from small to large and forming symmetric synapses, asymmetric
synapses, or no synapses. On the rAAV-GFP-Cre-injected side,
the mean numbers of NR1-labeled dendritic profiles were re-
duced by 80% (Fig. 2C) ( p 	 0.05). A similar reduction was
found for NR1-labeled somata and axons. Profiles on the rAAV-
GFP-Cre-injected side that lacked NR1 labeling were not degen-
erating, indicating that the absence of NR1 labeling was not at-
tributable to death or damage to NR1-expressing cells.
In the SCDH of the adult mouse, mRNAs for only two of the
four NR2 subunits, the 1 (NR2A) and 2 (NR2B), have been
observed (Watanabe et al., 1994). When we compared the ratio of
the immunolabeling of the ipsilateral (rAAV-GFP-Cre injected)
and contralateral sides of the dorsal horn in six mice, no differ-
ence was observed for either the 1 (96  6.6% SEM) or 2
(96.6  10.0% SEM) subunits (data not shown). Thus, the
knock-out of the NR1 subunit does not result in a compensatory
change in the NR2 subunits.
NR1 labeling has also been observed in primary sensory neu-
rons of the rat DRG (Shigemoto et al., 1992; Petralia et al., 1994;
Wang et al., 1999b). To determine whether IPI administration of
rAAV-GFP-Cre was associated with retrograde transport of the
vectors, we examined the ipsilateral and contralateral DRG for
GFP immunolabeling and NR1 mRNA (in situ) in sections that
correspond to the lumbar spinal cord segments, where recombi-
nation had occurred after rAAV-GFP-Cre (n  14) or after
rAAV-GFP (n  9). No labeling for GFP was observed in the
DRG (Fig. 3A), nor was any evidence obtained of a decrease in
Figure 1. IPI of rAAV-GFP-Cre into the SCDH of a floxed NR1 mouse results in viral transduc-
tion, Cre-mediated recombination, and a spatiotemporal knock-out of the NR1 gene. A, B, On
the side ipsilateral to the injection of rAAV-GFP-Cre, viral transduction results in the expression
of GFP immunolabeling and the disappearance of NR1 mRNA as measured by in situ hybridiza-
tion. C, In the same tissue, the expression of the neuronal marker NeuN is unaffected when
ipsilateral and contralateral sides are compared.
Figure 2. IPI of rAAV-GFP-Cre into the SCDH of a floxed NR1 mouse results in a decrease in
NR1 protein that is confined to the ipsilateral (rAAV-GFP-Cre-injected) side of the SCDH. A, The
NR1 protein immunolabeling (light microscopy) that is seen on the contralateral (noninjected)
side (arrows) is absent on the ipsilateral side. B, Ultrastructural analysis (electron microscopy) of
the SCDH of a rAAV-GFP-Cre-injected mouse demonstrates a loss of NR1 protein labeling in
dendrites (u-d) and somata (u-s) compared with the contralateral side (NR1-d and NR1-s). N,
Nucleus. C, Measurement of the number of mean dendritic NR1 profiles indicates an 80% re-
duction in NR1 protein labeling on the rAAV-GFP-Cre-injected side. *p 0.05.
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NR1 mRNA on the ipsilateral side compared with the contralat-
eral side (Fig. 3B). We also examined sections from the thoracic
and cervical spinal cord and the brain and found no evidence for
the expression of GFP. The deletion of the NR1 subunit in fNR1
mice appeared to be confined to SCDH cells, primarily in
postsynaptic elements (dendrites and somata), and did not ex-
tend to the corresponding DRG cells that constitute the major
presynaptic source of NR1.
Effects of a spatiotemporal knock-out of the NR1 subunit on
NMDA and AMPA receptor currents and synaptic current
activity in lamina II neurons of the SCDH
We compared the electrophysiological responses of lamina II
neurons from C57BL/6 mice (the background strain of our fNR1
mice), which served as an untreated control, with those of fNR1
mice that had received rAAV-GFP or rAAV-GFP-Cre by IPI ad-
ministration 2 weeks before in thick transverse spinal cord
slices using the whole-cell patch-clamp recording technique
(Kohno et al., 1999; Moore et al., 2002).
Spontaneous EPSC activity, membrane resting potential, and
AMPA receptor-mediated current responses were unaffected
in rAAV-GFP or rAAV-GFP-Cre mice
The frequency and amplitude of spontaneous activity (EPSCs
recorded at 70 mV) observed in lamina II neurons were the
same in untreated C57BL/6 mice or fNR1 mice given either viral
vector (Fig. 4A). Furthermore, the resting membrane potential
(untreated,64 1 mV, n 12; rAAV-GFP,63 2 mV, n
12, p 0.66; rAAV-GFP-Cre,67 1 mV, n 15, p 0.12) in
viral vector-treated mice was also unaffected (data not shown).
To determine the effects of the viral vectors on AMPA receptor
function, AMPA (10 M) was bath-applied to spinal cord slices
from untreated, rAAV-GFP, and rAAV-GFP-Cre mice, voltage-
Figure 3. IPI of rAAV-GFP-Cre into the SCDH of a floxed NR1 mouse does not result in retro-
grade movement of the viral vector to the primary sensory neurons of the corresponding lumbar
DRGs. These DRGs represent the presynaptic afferent innervation of the SCDH. A, Immunolabel-
ing for GFP in the primary sensory neurons of the DRGs produced only a light background
labeling over the somata (S) and no labeling of the dorsal root afferents (DRA). B, In situ hybrid-
ization of the neurons of the DRG produced the same intensity and extent of NR1 mRNA labeling
of sensory neuron somata on the ipsilateral and contralateral sides.
Figure 4. Spontaneous currents, AMPA receptor-mediated currents, and AMPA-mediated
synaptic current activity are unaffected in lamina II neurons of the SCDH from rAAV-GFP or
rAAV-GFP-Cre mice. A–C, Whole-cell patch-clamp recordings were made in spinal cord slices
from C57BL/6 (untreated controls) or floxed NR1 mice that received IPIs of rAAV-GFP or rAAV-
GFP-Cre. A, The frequency and amplitude of spontaneous activity (EPSCs recorded at70 mV)
are the same in untreated C57BL/6 mice or floxed NR1 mice given either viral vector. B, AMPA
(10 M) was bath-applied to spinal cord slices from untreated, rAAV-GFP, and rAAV-GFP-Cre
mice. The neurons were voltage-clamped at a holding potential of70 mV in the presence of
TTX (1M). Bath application of AMPA evoked exactly the same response in all three groups. C,
When A fibers were fully activated by dorsal root stimulation, the monosynaptic AMPA
receptor-mediated primary afferent-evoked EPSC amplitudes (70 mV) were similar in all
three groups.
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clamped at a holding potential of 70 mV in the presence of
tetrodotoxin (TTX, 1 M). Bath application of AMPA evoked
exactly the same response in all three groups (Fig. 4B), indicating
that this glutamatergic ionotropic receptor was unaffected by the
viral injection.
Current responses mediated by NMDA receptors were
diminished in rAAV-GFP-Cre mice
To investigate whether the viral vectors produced changes in
NMDA receptor function, NMDA (50M) was also bath-applied
to these same spinal cord slices from untreated, rAAV-GFP, and
rAAV-GFP-Cre mice, with the voltage of the lamina II neurons
clamped at four different holding potentials (70, 40, 0, and
40 mV) in the presence of TTX (1M) to inhibit synaptic effects
resulting from the application of NMDA. Exogenously applied
NMDA elicits an inward current at70 or40 mV and induces
an outward current at 40 mV (Fig. 5A). Most neurons from
untreated and rAAV-GFP mice had NMDA receptor compo-
nents at 70 mV (untreated, 45  8 pA, n  11; rAAV-GFP,
34 8 pA, n 7, p 0.40),40 mV (untreated,59 8 pA,
n  10; rAAV-GFP, 49 6 pA, n  7, p  0.33), or 40 mV
(untreated, 102 18 pA, n 12; rAAV-GFP, 77 15 pA, n 6,
p  0.37) (Fig. 5A). In contrast, the neurons from rAAV-GFP-
Cre-injected mice exhibited minimal or absent NMDA receptor
responses at 70 mV (6  2 pA; n  10; p 	 0.01) (Fig. 5A),
40 mV (8  2 pA; n  8; p 	 0.01) (Fig. 5A), or 40 mV
(17 5 pA; n 10; p	 0.01) (Fig. 5A). The reduction in NMDA
receptor current responses after applied NMDA averaged 86% (Fig.
5A). Therefore, the characteristic current–voltage relationship was
abolished in animals that received rAAV-GFP-Cre (Fig. 5B).
Synaptic responses mediated by the NMDA receptor, but not
the AMPA receptor, were diminished in rAAV-GFP-Cre mice
In spinal cord slices from untreated, rAAV-GFP, and rAAV-GFP-
Cre mice, when A fibers were fully activated by dorsal root stim-
ulation, the monosynaptic AMPA receptor-mediated primary
afferent-evoked EPSC amplitudes (70 mV) were similar in all
three populations (untreated, 126  16 pA, n  9; rAAV-GFP,
132 19 pA, n 5, p 0.83; rAAV-GFP-Cre, 102 20 pA, n
7, p  0.35) (Fig. 4C). Next, we investigated NMDA receptor-
mediated synaptic responses from untreated and rAAV-GFP-Cre
mice in the presence of a glycine receptor antagonist (strychnine;
1M), a GABAA receptor antagonist (bicuculline; 20M), and an
AMPA/kainate receptor antagonist (CNQX; 20M). Under these
conditions, NMDA receptor-mediated primary afferent-evoked
EPSC amplitudes (at 40 mV) were significantly decreased by
88% in rAAV-GFP-Cre mice (untreated, 84  12 pA, n  11;
rAAV-GFP-Cre, 7 2 pA, n 7, p	 0.01) (Fig. 5C).
Effects of a spatiotemporal knock-out of the NR1 subunit
on motor coordination and acute mechanical and
thermal stimuli
Because fNR1 mice have been reported to grow and mate nor-
mally and to exhibit behavior responses, including spatial mem-
ory, that are indistinguishable from those of wild-type mice
(Tsien et al., 1996), we focused our evaluation on any conse-
quences that might result from the IPI procedure. To do this, we
compared groups of fNR1 mice before and at 2– 4 weeks after IPI
of either the control vector (rAAV-GFP) or the Cre-expressing
vector (rAAV-GFP-Cre). The rotarod test measures the ability of
a mouse to maintain balance and demonstrate motor coordina-
tion (Crawley and Paylor, 1997). Motor coordination was not
affected by IPI of either viral vector (Fig. 6A). Next, we deter-
mined whether IPI affected non-injury-inducing noxious stim-
uli, including that resulting from placing the tail in water main-
tained at three different elevated temperatures, the latency to
respond to an acutely painful low-intensity or high-intensity
thermal stimulus delivered to the paw, the paw threshold re-
Figure 5. CurrentandsynapticresponsesmediatedbyNMDAreceptorswerediminishedinrAAV-GFP-
Cre mice. A–C, Whole-cell patch-clamp recordings were made in spinal cord slices from C57BL/6 (untreated
controls) or floxed NR1 mice that received IPIs of rAAV-GFP or rAAV-GFP-Cre. These recordings were made
from the same cells as those examined for AMPA responses (Fig. 4). A, NMDA (50M) was bath-applied to
spinal cord slices from untreated, rAAV-GFP, and rAAV-GFP-Cre mice, with the voltage of the lamina II neu-
ronsclampedatfourdifferentholdingpotentials(70,40,0,and40mV)inthepresenceofTTX(1M)
to inhibit synaptic effects resulting from the application of NMDA. Exogenously applied NMDA elicits an in-
ward current at70 or40 mV and induces outward current at40 mV. Most neurons from untreated
and rAAV-GFP mice had NMDA receptor components at70,40, or40 mV. In contrast, the neurons
from rAAV-GFP-Cre-injected mice exhibited minimal or absent NMDA receptor responses at each of these
potentials (*p	0.01). B, The I–V that ischaracteristic of theNMDAionchannel ispresent inuntreated and
rAAV-GFPmicebutabsentinrAAV-GFP-Cremice.C,NMDAreceptor-mediatedprimaryafferent-evokedEPSC
amplitudes (at40 mV) are significantly decreased in rAAV-GFP-Cre mice compared with untreated mice.
The responses were measured in the presence of a glycine receptor antagonist (strychnine; 1M), a GABAA
receptor antagonist (bicuculline; 20 M), and an AMPA/kainate receptor antagonist (CNQX; 20 M).
(*p	0.01).
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sponse to a nonpainful mechanical stimulus (von Frey fila-
ments), or the paw threshold response to a cold stimulus (evap-
orating acetone). Compared with the responses before IPI, the
administration of either viral vector did not alter the latency for
thermal tail withdrawal at 48, 52.5, or 55°C (Fig. 6B); the latency
for thermal paw withdrawal at low (Fig. 6C) or high intensity
(Fig. 6D); the mechanical stimulus threshold (Fig. 6B); or the
cold stimulus threshold (Fig. 6F). When the paw ipsilateral to the
IPI was compared with the contralateral paw, no difference was
observed in the responses to acute mechanical or thermal stimuli
(Fig. 6C–F). Neither the IPI procedure for delivering the virus
nor the spatiotemporal knock-out of NR1 affected non-injury-
inducing stimuli.
Effects of a spatiotemporal knock-out of the NR1 subunit on
injury-induced pain
Formalin was injected into the paws of fNR1 mice that had re-
ceived either the vehicle for the vector (PBS) 2– 4 weeks previ-
ously (n 11), rAAV-GFP (n 6), or rAAV-GFP-Cre (n 9) by
IPI. Intraplantar formalin evokes two phases of spontaneous
pain-related behavior: an immediate, short-lasting phase attrib-
utable to the direct irritant effects of the chemical, and a slower-
onset, longer-lasting phase that reflects a combination of ongoing
sensory input and central sensitization (Coderre et al., 1990;
Coderre and Melzack, 1992; Puig and Sorkin, 1995; McCall et al.,
1996). The formalin-induced pain (licking and biting the affected
paw) that occurred during phase 2 (10 – 60 min after the formalin
injection) was decreased by 73% in the rAAV-GFP-Cre group but
not in the vehicle-treated and rAAV-GFP-treated animals (Fig.
7A). Because no difference was observed between vehicle and
rAAV-GFP treatments, these two control groups were combined
so that we could better compare the responses at 5 min intervals
in the control mice (n  17) and rAAV-GFP-Cre-treated mice
(n  9). Figure 7B shows that during the peak of the phase 2
response (15–35 min after formalin), the rAAV-GFP-Cre-treated
group showed significantly less injury-induced pain.
Discussion
A conditional knock-out can delete a gene both spatially and
temporally (Tsien et al., 1996), avoiding the complications result-
ing from deletion of the gene in systems other than those that
affect the response, gene redundancy during development, or
even embryonic lethality (Tsien et al., 1996). The original ap-
proach used (Tsien et al., 1996), although successful, requires the
mating of a mutant mouse containing the loxP sites in the gene of
interest (a floxed mouse) with a transgenic mouse that expresses
Figure 6. A spatiotemporal knock-out of NR1 in the SCDH of floxed NR1 mice does not affect
motor coordination and non-injury-inducing stimuli. A, Motor coordination was measured us-
ing the rotarod test. B, A thermal stimulus was applied to the tail (thermal tail withdrawal
threshold) at 48, 52.5, and 55°C. C, D, A brief thermal stimulus of low ( C) and higher ( D)
intensity was applied to the paw. E, Mechanical (tactile) stimuli were applied using von Frey
hairs. F, Cold sensitivity was measured by applying a drop of acetone to the paw.
Figure 7. A spatiotemporal knock-out of NR1 in the SCDH of fNR1 mice significantly de-
creases the painful response to an injury-inducing stimulus measured during phase 2 of the
formalin test. A, B, Intraplantar injection of formalin (5%) results in licking activity that can be
divided into two phases, phase 1, which encompasses the first 0 –10 min, and a second phase,
which begins at 10 min and continues to 60 min (phase 2). A, During phase 1, the area under the
response to formalin over the time curve is the same in fNR1 mice that received vehicle, rAAV-
GFP, or rAAV-GFP-Cre treatment. During phase 2, the response of rAAV-GFP-Cre mice is reduced
70% compared with vehicle and rAAV-GFP mice (*p0.05). B, When the data are presented as
the time course of the response at 5 min intervals, rAAV-GFP-Cre mice show a diminished pain
response at 5–35 (and at 45) min after formalin (*p 0.05).
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the Cre recombination enzyme under the control of a region-
specific promoter. However, region-specific promoters for the
SCDH are not yet available, and expression of the Cre transgene
integrated at different genomic locations often varies because of
position variegation effects, necessitating the generation and
analysis of multiple transgenic founder lines (Kaspar et al.,
2002b). Thus, we used rAAV to deliver Cre recombinase and GFP
to the target cells in the SCDH.
Viral vectors administered into CSF are taken up by menin-
geal cells, so that viral transduction of spinal cord cells after in-
trathecal administration is minimal (Mannes et al., 1998). How-
ever, microinjection of viral vectors directly into the brain or
spinal cord (Kaplitt and Makimura, 1997; Peel et al., 1997;
Mannes et al., 1998; Kaspar et al., 2002b) results in significant
neuronal transduction. For rAAV-GFP-Cre, maximum recombi-
nation in the brain requires 7–14 d after injection (Kaspar et al.,
2002b), and we found no difference in GFP expression and NR1
mRNA reduction in SCDH between 14 d and 6 weeks. Using
multiple injections, we were able to transduce most cells in the
target area, resulting in a maximum reduction of 80% in NR1
mRNA and protein. This estimate of the percentage of reduction
probably represents an underestimate of the actual reduction in
postsynaptic NR1, because presynaptic NR1 is not affected and
therefore contributes residual NR1 protein and mRNA. As in the
brain (Kaspar et al., 2002b), viral transduction was neurotropic,
with GFP expression confined to NeuN-positive cells and absent
in glia (GFAP-positive cells). Kaspar et al. (2002b) and this study
found no evidence of neuronal toxicity after rAAV-GFP-Cre at
the light-microscopic level, and we also observed none at the
ultrastructural level. Although retrograde transport of rAAV vec-
tors and transgene expression in specific projection neurons in
the entorhinal cortex and substantia nigra has been reported pre-
viously (Kaspar et al., 2002a), we did not observe transport of
either rAAV vector to the sensory neurons of the DRG that in-
nervate the lumbar SCDH, to thoracic or cervical spinal cord, or
to supraspinal sites. Thus, rAAV-GFP-Cre appears to produce a
loss of NR1 that is confined to SCDH somata and dendrites.
These SCDH components comprise the postsynaptic targets of
primary afferents that originate in the DRG.
The specific functional consequences of the deletion of NR1
demonstrate the distinct advantages of the use of rAAV vectors to
produce a spatiotemporal gene knock-out in the adult CNS. This
approach can be readily adapted to other receptor–ion channels
in the nervous system and will allow the examination of receptor
function localized to a particular target area to be examined with-
out the confounds that occur with constitutive knock-outs,
thereby providing an important new strategy for defining recep-
tor function without requiring specific antagonists, which is of
enormous benefit in the evaluation of the many new targets that
mass genomic screens are revealing. In addition, the spatial local-
ization of vector transduction to somata of SCDH allows conclu-
sions as to the primary postsynaptic locus of the functional re-
ceptor with a degree of certainty not possible with current
pharmacological approaches.
Native NMDA receptors are hetero-oligomers of subunits
(Sugihara et al., 1992; Hollmann and Heinemann, 1994) that, in
the mouse, include NR1 (1), 1–4 (NR2A–NR2D), and NR3
(Dingledine et al., 1999). In rat dorsal horn NMDA, single-cell
reverse transcriptase-PCR has detected the NR1 subunit and each
of the four NR2B subunits, with the NR2B subunit being the
predominant NR2 subunit (Karlsson et al., 2002). Studies of ex-
pressed NMDA receptors (Dingledine et al., 1999) and neurons
of a CA1 hippocampal NR1 knock-out mouse (Tsien et al., 1996)
show that the NR1 subunit is required to generate characteristic
NMDA currents, and our results are compatible with this, show-
ing a loss of response both to bath-applied NMDA and to NMDA
receptor-mediated synaptic currents after NR1 deletion.
Our results demonstrate that NMDA receptors mediate criti-
cal aspects of the intensity coding that differentiates the responses
to injury-inducing and nondamaging noxious stimuli (Woolf
and Costigan, 1999). The application of acute, high-intensity,
nondamaging thermal stimuli to the skin (e.g., paw or tail) acti-
vates high-threshold primary afferents, C and A fibers, that re-
sult within seconds in transient, well localized pain. We found
that these responses, along with those to normal mechanical (tac-
tile) stimuli, do not require the presence of functional NMDA
receptors in the spinal cord. Synaptic transmission after these
stimuli is mediated by AMPA receptors, which generate fast
EPSCs. In the NR1 knock-out mice, AMPA receptor-mediated
currents are not altered in the cells in which NMDA-mediated
currents are abolished. Thus, the fast, early warning protective
pain system is preserved in the absence of NMDA receptors.
These results are consistent with the observation that NMDA
receptor antagonists given systemically or intrathecally do not
modify baseline responses to acutely painful stimuli (Yaksh,
1999).
Noxious tissue-damaging stimuli generate a complex cascade
of transmitters and modulators in the dorsal horn that initiate
activity-dependent neuroplastic changes that result in pain hy-
persensitivity (Woolf and Costigan, 1999). NMDA receptors
open more slowly and remain open longer than AMPA receptors,
and this slow time course allows for a summation of membrane
excitability by successive C fiber-induced depolarizations that
remove the voltage-dependent Mg 2 block of the NMDA recep-
tor, amplifying the response to each subsequent input, a phe-
nomenon described as windup (Woolf and Costigan, 1999).
Open NMDA channels allow a large Na and Ca 2 influx
through the postsynaptic membrane, resulting in the slow-rising,
long-duration EPSC and an increase in intracellular Ca 2. The
increase in intracellular Ca 2 produces a cascade of molecular
events leading to central sensitization. Post-translational changes
in dorsal horn neurons include the activation of protein kinases
that phosphorylate membrane-bound NMDA receptors and al-
ter their functional properties, increasing membrane excitability.
The phosphorylation of the NMDA receptor results in changes in
NMDA receptor channel kinetics and a reduction in its voltage-
dependent Mg 2 block (Chen and Huang, 1992; Wang and
Salter, 1994; Yu et al., 1997). Both of these changes augment
subsequent responsiveness to synaptically released glutamate, in-
creasing synaptic strength and enabling previously subthreshold
inputs to drive the output of the cell (Woolf and King, 1990). This
effective increase in gain alters receptive field properties (Cook et
al., 1987; Simone et al., 1989; Woolf and King, 1990) and pain
sensitivity, causing hypersensitivity far beyond the site and dura-
tion of the C fiber activating stimulus that initiated the central
sensitization (Torebjork et al., 1992). NMDA receptor antago-
nists can block windup, central sensitization, and the consequent
pain hypersensitivity (Woolf and Thompson, 1991; Woolf and
Costigan, 1999). However, determining whether the effect is pre-
synaptic or postsynaptic and limited to the lumbar dorsal horn, as
well as the extent of its contribution, has not been possible to
establish using pharmacological techniques.
The formalin test is the most widely used method for assessing
the antihypersensitivity efficacy of NMDA receptor antagonists
(Coderre and Melzack, 1992; Yaksh, 1999). The immediate re-
sponse to intraplantar formalin results from the stimulation of
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primary afferent nociceptors (Puig and Sorkin, 1995; McCall et
al., 1996), whereas the latter response, phase 2, is generated by a
reduced but continuing stimulation of peripheral nociceptors
(Puig and Sorkin, 1995; McCall et al., 1996), activation of inflam-
matory mediators (Taylor et al., 2000), and central sensitization
triggered by the phase 1 input from the periphery and maintained
by the input associated with phase 2 (Coderre et al., 1990;
Coderre and Melzack, 1992; Henry et al., 1999; Woolf and Costi-
gan, 1999). Pharmacological studies using centrally applied re-
ceptor antagonists indicate a contribution of NMDA as well as
neurokinin (NK1) receptors in the behavioral response seen dur-
ing phase 2 of formalin (Coderre and Melzack, 1992; Yaksh,
1999). However, these studies cannot discriminate between a
presynaptic versus postsynaptic action of the drug, ensure that all
of the available receptors have been blocked, or ensure that those
that are blocked are limited to the dorsal horn. Our results point
to a critical role for postsynaptic NMDA receptors in the lumbar
dorsal horn in injury-induced pain and unambiguously identify
the in vivo anatomical locus of the responsible NMDA receptors.
Furthermore, our results relate directly to the continuing contro-
versy over the relative contribution to phase 2 pain of continued
peripheral input (Puig and Sorkin, 1995; Henry et al., 1999), NK1
receptors, and NMDA receptors (Elliott et al., 1994; Shimoyama
et al., 1997). Our results demonstrate that the NMDA receptor is
the key player in the pain hypersensitivity expressed during phase
2 of the formalin response.
Localized deletion of NR1 preserves the responses to acute
nondamaging stimuli while attenuating injury-induced re-
sponses. This finding suggests that spinally administered com-
pounds that remain localized, including NMDA receptor antag-
onists, NR1 antisense (Rydh-Rinder et al., 2001; Yukhananov et
al., 2002), or RNA interference targeted to NR1 may yield safe
and useful therapeutic procedures for pain that have not been
achieved with available NMDA receptor antagonists (Chizh et al.,
2001).
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